Pelvic Angiography in Non-Responders to Phosphodiesterase-5 Inhibitors (PANPI)

Study Overview
=================
Brief Summary
-----------------
The specific aim of this pilot study is to describe the angiographic prevalence and pattern of internal pudendal artery (and associated inflow vessel) atherosclerosis in patients with erectile dysfunction who are non-responsive to PDE-5 inhibitors (i.e., Viagra) who are referred for clinically-indicated cardiac catheterization.

Detailed Description
-----------------
The specific aim of this study is to determine if the deep penile arteries can be seen angiographically from the iliac arteries to delineate penile vasculature. Significant obstructive atherosclerotic disease of the deep penile arteries may be present in impotent males. The etiology of erectile dysfunction is multifactorial and may involve vascular disease, endocrine disorders, neurologic disease, prescription medications, psychological issues and/or trauma in any given patient. Vascular disease in patients with erectile dysfunction may be due to trauma, congenital anomalies, or atherosclerosis.

Official Title
-----------------
Pelvic Angiography in Non-Responders to Phosphodiesterase-5 Inhibitors (PANPI)

Conditions
-----------------
Erectile Dysfunction

Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Male patients at least 50 years erectile dysfunction dissatisfaction with their use of a phosphodiesterase-5 inhibitor coronary artery disease (or at risk for coronary artery disease) undergoing diagnostic cardiac catheterization or patients with peripheral vascular disease undergoing peripheral arteriography Exclusion Criteria: Patients who respond favorably to phosphodiesterase-5 inhibitors known non-vascular etiologies of their erectile dysfunction probable neurogenic erectile dysfunction due to radiation injury, surgery, or transurethral resection of the prostate calculated GFR < 60 ml/min/1.73 m2 will also be excluded disease that necessitates complex percutaneous intervention will be excluded per the investigators discretion

Ages Eligible for Study
-----------------
Minimum Age: 50 Years

Sexes Eligible for Study
-----------------
Male

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------
What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Distal aortography with iliofemoral run-off will be performed to evaluate disease in the common and internal iliac arteries. |  | During Procedural Cath | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Selective angiography of the internal pudendal artery (and accessory pudendal artery if present) will be performed bilaterally. |  | During Procedural Cath | 
| Intra-arterial nitroglycerin (or papaverine or tolazoline if nitroglycerin is contraindicated) will be used to facilitate angiographic visualization of the internal pudendal and penile arteries. |  | During Procedural Cath | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
ED, Erectile Dysfunction